{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:34:31Z","timestamp":1792506871123,"version":"4.5.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate the association between prophylactic ureteral stent placement at the time of hysterectomy for placenta accreta spectrum and genitourinary injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective cohort study of patients with placenta accreta spectrum who underwent hysterectomy at two referral centers from 2001 to 2021. The exposure was prophylactic ureteral stent placement. The primary outcome, genitourinary injury, was a composite of bladder injury, ureteral injury, or vesicovaginal fistula. Secondary outcomes included components of the primary outcome. We evaluated differences between groups using \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      and\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      test. To evaluate differences in the primary outcome, we reported odds ratios (ORs) and adjusted odds ratios (aORs) using multivariable logistic regression analyses to control for potential confounding variables. We used a Cochran-Armitage \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      trend test to evaluate difference in stent use and injury over time.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      In total, 236 patients were included. Prophylactic ureteral stents were used in 156 surgeries (66%). Overall, genitourinary injury occurred less frequently in the stent group compared with the no stent group (28% vs 51%, OR 0.37, 95% CI 0.21\u20130.65). This association persisted after controlling for urgency of delivery, three or more prior cesarean deliveries, and whether a gynecologic oncologist was present (aOR 0.27, 95% CI 0.14\u20130.52). Unintentional bladder injury occurred less frequently in the stent group compared with the no stent group (13% vs 25%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.018), as did ureteral injury (2% vs 9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.019).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Prophylactic ureteral stent placement was associated with a decreased risk of genitourinary injury during hysterectomy for placenta accreta spectrum.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004957","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T17:01:49Z","timestamp":1665075709000},"page":"806-811","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":34,"title":["Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum"],"prefix":"10.1097","volume":"140","author":[{"given":"Morgan A.","family":"Scaglione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda A.","family":"Allshouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana R.","family":"Canfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah D.","family":"Mclaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim A.","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Ware","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Dood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle P.","family":"Debbink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett D.","family":"Einerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","article-title":"Placenta accreta spectrum","volume":"378","author":"Silver","year":"2018","journal-title":"N Engl J Med"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ajog.2004.12.074","article-title":"Abnormal placentation: twenty-year analysis","volume":"192","author":"Wu","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ajog.2010.09.013","article-title":"Placenta accreta","volume":"203","author":"Belfort","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-0528.2008.02037.x","article-title":"Optimal management strategies for placenta accreta","volume":"116","author":"Eller","year":"2009","journal-title":"BJOG"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/14767058.2019.1609935","article-title":"Use of routine ureteral stents in cesarean hysterectomy for placenta accreta","volume":"34","author":"Crocetto","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"245.e1","DOI":"10.1016\/j.ajog.2021.08.010","article-title":"Urologic morbidity associated with placenta accreta spectrum surgeries: single-center experience with a multidisciplinary team","volume":"226","author":"Erfani","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/14767058.2011.576720","article-title":"Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review","volume":"25","author":"Tam Tam","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ajog.2019.02.054","article-title":"Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta","volume":"220","author":"Collins","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)- a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1038\/s41379-020-0569-1","article-title":"Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel","volume":"33","author":"Hecht","year":"2020","journal-title":"Mod Pathol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:01:34Z","timestamp":1789556494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004957","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"2022-05-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}